CD34 and graft versus host disease: The dose of infused PBSC from the initial donor was increased with CsA prophylaxis of GvHD, which containing peripheral blood mononuclear cells (PBMC, 1.02×108/kg) containing CD34+ cells (1.17×106/kg) and CD3+ cells (0.8×107/kg) without the induction of GvHD.